Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 195

1.

Immunotherapy with costimulatory dendritic cells to control autoimmune inflammation.

O'Sullivan BJ, Pai S, Street S, An X, MacDonald KP, Wong M, Strutton G, Gerondakis S, Steptoe RJ, de St Groth BF, Hill GR, Thomas R.

J Immunol. 2011 Oct 15;187(8):4018-30. doi: 10.4049/jimmunol.1101727. Epub 2011 Sep 7.

2.

Suppression of ongoing experimental autoimmune myasthenia gravis by transfer of RelB-silenced bone marrow dentritic cells is associated with a change from a T helper Th17/Th1 to a Th2 and FoxP3+ regulatory T-cell profile.

Yang H, Zhang Y, Wu M, Li J, Zhou W, Li G, Li X, Xiao B, Christadoss P.

Inflamm Res. 2010 Mar;59(3):197-205. doi: 10.1007/s00011-009-0087-6. Epub 2009 Sep 19.

PMID:
19768385
3.

A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation.

Baban B, Hansen AM, Chandler PR, Manlapat A, Bingaman A, Kahler DJ, Munn DH, Mellor AL.

Int Immunol. 2005 Jul;17(7):909-19. Epub 2005 Jun 20.

PMID:
15967784
4.

Essential role of dendritic cell CD80/CD86 costimulation in the induction, but not reactivation, of TH2 effector responses in a mouse model of asthma.

van Rijt LS, Vos N, Willart M, Kleinjan A, Coyle AJ, Hoogsteden HC, Lambrecht BN.

J Allergy Clin Immunol. 2004 Jul;114(1):166-73.

PMID:
15241361
6.

Dendritic cells modulated by innate immunity improve collagen-induced arthritis and induce regulatory T cells in vivo.

Jaen O, Rullé S, Bessis N, Zago A, Boissier MC, Falgarone G.

Immunology. 2009 Jan;126(1):35-44. doi: 10.1111/j.1365-2567.2008.02875.x. Epub 2008 Aug 27.

7.

Treatment of autoimmune arthritis using RNA interference-modulated dendritic cells.

Zheng X, Suzuki M, Ichim TE, Zhang X, Sun H, Zhu F, Shunnar A, Garcia B, Inman RD, Min W.

J Immunol. 2010 Jun 1;184(11):6457-64. doi: 10.4049/jimmunol.0901717. Epub 2010 Apr 30.

8.

Interleukin-1β produced in response to islet autoantigen presentation differentiates T-helper 17 cells at the expense of regulatory T-cells: Implications for the timing of tolerizing immunotherapy.

Bertin-Maghit S, Pang D, O'Sullivan B, Best S, Duggan E, Paul S, Thomas H, Kay TW, Harrison LC, Steptoe R, Thomas R.

Diabetes. 2011 Jan;60(1):248-57. doi: 10.2337/db10-0104. Epub 2010 Oct 27.

9.

Dual effects of TRAIL in suppression of autoimmunity: the inhibition of Th1 cells and the promotion of regulatory T cells.

Ikeda T, Hirata S, Fukushima S, Matsunaga Y, Ito T, Uchino M, Nishimura Y, Senju S.

J Immunol. 2010 Nov 1;185(9):5259-67. doi: 10.4049/jimmunol.0902797. Epub 2010 Oct 4.

10.

Comparative analysis of dendritic cells and anti-CD3/CD28 expanded regulatory T cells for application in transplantation.

Zeng M, Guinet E, Nouri-Shirazi M.

Transpl Immunol. 2009 Dec;22(1-2):82-92. doi: 10.1016/j.trim.2009.07.004. Epub 2009 Jul 25.

PMID:
19635560
12.

CD4+ CD25+ regulatory T cells control T helper cell type 1 responses to foreign antigens induced by mature dendritic cells in vivo.

Oldenhove G, de Heusch M, Urbain-Vansanten G, Urbain J, Maliszewski C, Leo O, Moser M.

J Exp Med. 2003 Jul 21;198(2):259-66.

13.
14.

Dendritic cell-specific disruption of TGF-β receptor II leads to altered regulatory T cell phenotype and spontaneous multiorgan autoimmunity.

Ramalingam R, Larmonier CB, Thurston RD, Midura-Kiela MT, Zheng SG, Ghishan FK, Kiela PR.

J Immunol. 2012 Oct 15;189(8):3878-93. doi: 10.4049/jimmunol.1201029. Epub 2012 Sep 12.

15.

Induction of tolerogenic dendritic cells by vitamin D receptor agonists.

Adorini L, Penna G.

Handb Exp Pharmacol. 2009;(188):251-73. doi: 10.1007/978-3-540-71029-5_12. Review.

PMID:
19031030
16.

Dendritic cells and CD28 costimulation are required to sustain virus-specific CD8+ T cell responses during the effector phase in vivo.

Dolfi DV, Duttagupta PA, Boesteanu AC, Mueller YM, Oliai CH, Borowski AB, Katsikis PD.

J Immunol. 2011 Apr 15;186(8):4599-608. doi: 10.4049/jimmunol.1001972. Epub 2011 Mar 9.

17.

Regulation of human auto- and alloreactive T cells by indoleamine 2,3-dioxygenase (IDO)-producing dendritic cells: too much ado about IDO?

Terness P, Chuang JJ, Bauer T, Jiga L, Opelz G.

Blood. 2005 Mar 15;105(6):2480-6. Epub 2004 Nov 30.

18.

Inhibition of nuclear factor-kappa B enhances the capacity of immature dendritic cells to induce antigen-specific tolerance in experimental autoimmune encephalomyelitis.

Iruretagoyena MI, Sepúlveda SE, Lezana JP, Hermoso M, Bronfman M, Gutiérrez MA, Jacobelli SH, Kalergis AM.

J Pharmacol Exp Ther. 2006 Jul;318(1):59-67. Epub 2006 Apr 5.

19.

Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation.

Onishi Y, Fehervari Z, Yamaguchi T, Sakaguchi S.

Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):10113-8. doi: 10.1073/pnas.0711106105. Epub 2008 Jul 17.

20.

A defective NF-kappa B/RelB pathway in autoimmune-prone New Zealand black mice is associated with inefficient expansion of thymocyte and dendritic cells.

Valéro R, Baron ML, Guérin S, Béliard S, Lelouard H, Kahn-Perles B, Vialettes B, Nguyen C, Imbert J, Naquet P.

J Immunol. 2002 Jul 1;169(1):185-92.

Supplemental Content

Support Center